Quarterly Report • Nov 4, 2025
Quarterly Report
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 0095G
Commercial Intnl Bank (Egypt) SAE
03 November 2025
![]() |
Condensed Separate Interim Statement of Financial Position as at September 30, 2025
Notes
Sep. 30, 2025
Dec. 31, 2024
Assets
Cash and balances at the central bank
10
20,916,631
136,165,920
Due from banks
11
228,152,325
270,089,441
Loans and advances to banks, net
13
26,914,884
9,555,410
Loans and advances to customers, net
14
452,110,898
340,955,698
Derivative financial instruments
1,222,908
819,711
Financial investments
- Financial Assets at Fair Value through P&L
15
2,203,869
-
- Financial Assets at Fair Value through OCI
15
329,796,707
233,029,903
- Financial Assets at Amortized cost
15
228,915,634
167,276,956
Investments in subsidiaries and associates
16
1,255,421
871,525
Non-current assets held for sale
30
159,828
159,828
Other assets
17
49,915,056
44,175,232
Deferred tax assets
2,457,493
2,337,304
Property and equipment
18
5,470,642
3,881,620
Total assets
1,349,492,296
1,209,318,548
Liabilities and equity
Liabilities
Due to banks
19
7,043,881
2,317,715
Due to customers
20
1,043,204,762
967,895,387
Derivative financial instruments
223,670
100,571
Current income tax liabilities
15,857,818
18,327,968
Other liabilities
21
26,802,780
21,347,499
Issued debt instruments
22
4,779,461
5,067,781
Other loans
30,249,278
23,962,389
Other provisions
23
14,478,190
18,613,060
Total liabilities
1,142,639,840
1,057,632,370
Equity
Issued and paid capital
30,708,510
30,431,580
Reserves
105,209,974
63,125,912
Reserve for employee stock ownership plan (ESOP)
2,071,247
1,868,235
Retained earnings*
68,862,725
56,260,451
Total equity and net profit for the period / year
206,852,456
151,686,178
Total liabilities and equity
1,349,492,296
1,209,318,548
The accompanying notes are an integral part of these financial statements.
(Review report attached)
*
Including net profit for the period
| Condensed Separate Interim Income Statement for the period ended September 30, 2025 | ||||||
| Last 9 Months | Last 9 Months | |||||
| Notes | Sep. 30, 2025 | Sep. 30, 2024 | ||||
| Interest and similar income | 157,761,416 | 130,537,149 | ||||
| Interest and similar expense | (79,403,286) | (65,010,779) | ||||
| Net interest income | 78,358,130 | 65,526,370 | ||||
| Fee and commission income | 11,565,784 | 9,257,495 | ||||
| Fee and commission expense | (5,224,939) | (4,048,928) | ||||
| Net fee and commission income | 6,340,845 | 5,208,567 | ||||
| Dividend income | 125,185 | 100,858 | ||||
| Net trading income | 6 | 1,276,502 | 18,177,630 | |||
| Profits (Losses) on financial investments | 15.1 | 598,228 | 377,992 | |||
| Administrative expenses | (11,880,346) | (8,795,429) | ||||
| Other operating income (expenses) | 7 | 687,384 | (17,980,232) | |||
| Impairment release (charges) for credit losses | 9 | 7,976,997 | (3,741,208) | |||
| Profit before income tax | 83,482,925 | 58,874,548 | ||||
| Income tax expense | 27 | (21,867,730) | (16,964,163) | |||
| Deferred tax assets (Liabilities) | 27 | 592,311 | 646,991 | |||
| Net profit for the period | 62,207,506 | 42,557,376 | ||||
| Earnings per share | 8 | |||||
| Basic | 18.54 | 12.50 | ||||
| Diluted | 18.36 | 12.38 | ||||
| Condensed Separate Interim Statement of Comprehensive Income for the period ended September 30, 2025 | ||||||||
| Last 9 Months | Last 9 Months | |||||||
| Sep. 30, 2025 | Sep. 30, 2024 | |||||||
| Net profit for the period | 62,207,506 | 42,557,376 | ||||||
| Transferred to RE from financial assets at fair value through OCI | 3,586 | (370,224) | ||||||
| Net change on financial assets at fair value through comprehensive income after tax | 6,805,836 | 8,284,110 | ||||||
| Effect of ECL on fair value of debt instruments measured at fair value through comprehensive income | (399,884) | 624,524 | ||||||
| Total comprehensive income for the period | 68,617,044 | 51,095,786 | ||||||
| Condensed Separate Interim Cash Flows for the period ended September 30, 2025 | ||||
| Notes | Sep. 30, 2025 | Sep. 30, 2024 | ||
| Cash flow from operating activities | ||||
| Profit before income tax | 83,482,925 | 58,874,548 | ||
| Adjustments to reconcile profits to net cash provided by operating activities | ||||
| Fixed assets depreciation | 18 | 1,244,370 | 763,079 | |
| Impairment release/charge for credit losses (Loans and advances to customers and banks) | 9 | (7,980,073) | 4,226,051 | |
| Net charged/released for other provisions | 23 | (4,080,370) | 429,182 | |
| Impairment release/charge for credit losses (due from banks) | 9 | 151,236 | (5) | |
| Impairment release/charge for credit losses (financial investments) | 9 | (148,160) | (484,838) | |
| Impairment release/charge for other assets | - | (11,956) | ||
| Exchange revaluation differences for financial assets at fair value through OCI and AC | 4,669,694 | (18,536,183) | ||
| Revaluation differences impairment charge for Financial Assets at Fair value through OCI | (225,004) | 1,199,896 | ||
| Revaluation differences impairment charge for Financial Assets at Amortized cost | (16,709) | 107,207 | ||
| Revaluation differences impairment charge for due from banks | (7,813) | 107 | ||
| Net utilized/recovered for other provisions | 23 | (2,039) | (9,196) | |
| Exchange revaluation differences of other provisions | 23 | (52,461) | 3,963,023 | |
| Profits/losses from selling property and equipment | (8,006) | (2,254) | ||
| Profits/losses from selling financial investments at fair value through OCI | 15.1 | (416,668) | (377,992) | |
| Profits/losses from selling investments in associates | 15.1 | (181,560) | - | |
| Share based payments | 990,324 | 804,345 | ||
| Operating profits before changes in operating assets and liabilities | 77,419,686 | 50,945,014 | ||
| Net decrease / increase in assets and liabilities | ||||
| Due from banks | 158,353,929 | (24,748,544) | ||
| Financial assets at fair value through P&L | (2,203,869) | (2,066,889) | ||
| Derivative financial instruments | (306,569) | (229,127) | ||
| Loans and advances to banks and customers | (120,567,170) | (74,803,105) | ||
| Other assets | (2,706,703) | (14,036,648) | ||
| Due to banks | 19 | 4,726,166 | (8,606,431) | |
| Due to customers | 20 | 75,309,375 | 221,382,197 | |
| Current income tax obligations paid | (6,009,912) | (2,694,657) | ||
| Other liabilities | (12,872,687) | (6,305,033) | ||
| Net cash generated from (used in) operating activities | 171,142,246 | 138,836,777 | ||
| Cash flow from investing activities | ||||
| Proceeds from sale of investments in associates | 339,920 | 11,956 | ||
| Payments for investment in subsidiaries | (542,256) | (200,000) | ||
| Payments for purchases of property, equipment and branches construction | (5,833,944) | (2,284,236) | ||
| Proceeds from selling property and equipment | 7 | 8,006 | 2,254 | |
| Proceeds from redemption of financial assets at amortized cost | 21,249,023 | 1,093,724 | ||
| Payments for purchases of financial assets at amortized cost | (83,115,289) | (105,723,312) | ||
| Payments for purchases of financial assets at fair value through OCI | (192,334,673) | (21,646,713) | ||
| Proceeds from selling financial assets at fair value through OCI | 98,063,752 | 67,015,091 | ||
| Net cash generated from (used in) investing activities | (162,165,461) | (61,731,236) | ||
| Condensed Separate Interim Cash Flows for the period ended September 30, 2025 (Cont.) | ||||
| Sep. 30, 2025 | Sep. 30, 2024 | |||
| Cash flow from financing activities | ||||
| Other loans | 6,286,889 | 7,840,786 | ||
| Dividends | (14,714,434) | (5,078,792) | ||
| Issued debt instruments | (288,320) | 1,738,393 | ||
| Capital increase | 276,930 | 236,570 | ||
| Net cash generated from (used in) financing activities | (8,438,935) | 4,736,957 | ||
| Net (decrease) increase in cash and cash equivalent during the period | 537,850 | 81,842,498 | ||
| Beginning balance of cash and cash equivalent | 227,028,744 | 233,912,193 | ||
| Cash and cash equivalent at the end of the period | 227,566,594 | 315,754,691 | ||
| Cash and cash equivalent comprise: | ||||
| Cash and balances at the central bank | 10 | 20,916,631 | 94,285,689 | |
| Due from banks | 228,295,965 | 304,041,410 | ||
| Treasury bills and other governmental notes | 12 | 140,546,840 | 82,174,775 | |
| Obligatory reserve balance with CBE | (2,725,245) | (76,128,521) | ||
| Due from banks with maturity more than three months | (19,202,757) | (17,846,556) | ||
| Treasury bills and other governmental notes with maturity more than three months | (140,264,840) | (70,772,106) | ||
| Total cash and cash equivalent | 227,566,594 | 315,754,691 |
| Condensed Separate Interim statement of changes in shareholders' equity | |||||||||||
| Issued and paid capital | Legal reserve | General reserve | General risk reserve | Special reserve | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Total | |
| Sep. 30, 2024 | |||||||||||
| Beginning Balance at 1 January 2024 | 30,195,010 | 4,770,354 | 39,840,707 | 1,549,445 | - | 21,155 | (16,808,265) | 15,230 | 29,230,360 | 1,486,010 | 90,300,006 |
| Capital increase | 236,570 | - | - | - | - | - | - | - | - | - | 236,570 |
| Transferred to reserves | - | 1,438,320 | 22,582,085 | - | - | 1,663 | - | - | (23,398,943) | (623,125) | - |
| Dividend paid | - | - | - | - | - | - | - | - | (5,366,429) | - | (5,366,429) |
| Net profit for the period | - | - | - | - | - | - | - | - | 42,557,376 | - | 42,557,376 |
| Transferred to RE from financial assets at fair value through OCI | - | - | - | - | - | - | (370,224) | - | 370,224 | - | - |
| Net change on financial assets at fair value through OCI after tax | - | - | - | - | - | - | 8,284,110 | - | - | - | 8,284,110 |
| Transferred (from) to banking risk reserve | - | - | - | - | - | - | - | 2,694 | (2,694) | - | - |
| Effect of ECL on debt instruments measured at fair value through OCI | - | - | - | - | - | - | 624,524 | - | - | - | 624,524 |
| Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | - | 804,345 | 804,345 |
| Balance at 30 September 2024 | 30,431,580 | 6,208,674 | 62,422,792 | 1,549,445 | - | 22,818 | (8,269,855) | 17,924 | 43,389,894 | 1,667,230 | 137,440,502 |
| Issued and paid capital | Legal reserve | General reserve | General risk reserve | Special reserve | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Total | |
| Sep. 30, 2025 | |||||||||||
| Beginning Balance at 1 January 2025 | 30,431,580 | 6,208,674 | 62,422,792 | 1,549,445 | - | 22,818 | (7,095,741) | 17,924 | 56,260,451 | 1,868,235 | 151,686,178 |
| Capital increase | 276,930 | - | - | - | - | - | - | - | - | - | 276,930 |
| Transferred to reserves | - | 2,771,284 | 19,758,610 | - | - | 2,246 | - | - | (21,744,828) | (787,312) | - |
| Dividends paid | - | - | - | - | - | - | - | - | (14,714,434) | - | (14,714,434) |
| Net profit for the period | - | - | - | - | - | - | - | - | 62,207,506 | - | 62,207,506 |
| Transferred to RE from financial assets at fair value through OCI | - | - | - | - | - | - | 3,586 | - | (3,586) | - | - |
| Transferred from net profit to special reserve | - | - | - | - | 13,145,012 | - | - | - | (13,145,012) | - | - |
| Net change on financial assets at fair value through OCI after tax | - | - | - | - | - | - | 6,805,836 | - | - | - | 6,805,836 |
| Transferred (from) to banking risk reserve | - | - | - | - | - | - | - | (2,628) | 2,628 | - | - |
| Effect of ECL on debt instruments measured at fair value through OCI | - | - | - | - | - | - | (399,884) | - | - | - | (399,884) |
| Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | - | 990,324 | 990,324 |
| Balance at 30 September 2025 | 30,708,510 | 8,979,958 | 82,181,402 | 1,549,445 | 13,145,012 | 25,064 | (686,203) | 15,296 | 68,862,725 | 2,071,247 | 206,852,456 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
QRTUPGGWGUPAGBW
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.